Ramesh Rengan, MD, PhD, of ACC acts as lead author in head and neck therapy study

July 10, 2007

medpage Today

RANCHO MIRAGE, Calif., Jan 23 -- Chemoradiation allows many patients with node positive head-and-neck cancer to avoid additional surgery to the neck, a researcher reported here.

In a retrospective, non-randomized study, the combination treatment completely controlled the cancer in 85% of patients without the need for nodal dissection, said Ramesh Rengan, M.D., Ph.D., of the University of Pennsylvania, who carried out the work with colleagues while he was at Memorial Sloan-Kettering Cancer Center in New York... Read More